Positive results from hVIVO study of Cidara flu candidate
Study demonstrated a reduction in viral replication in the upper respiratory tract as well as influenza infection
Read More
Tag: Cidara
Cidara, Mundipharma team up to commercialise Rezafungin
The total transaction value could exceed $568 million.
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
